Estrace - oestrogenic drug - 17 - beta oestradiol which is identical to endogenous oestradiol (which is formed in an organism of women, since the first menstrual period up to a menopause), developed by ovaries. Exerts feminizing impact on an organism. Stimulates development of a uterus, uterine tubes, vaginas, stroma and channels of mammary glands, pigmentation in nipples and generative organs, formation of secondary sexual characteristics on female type, growth and closing of epiphysis of long tubular bones.

Blocks the final stage of HCl secretion, reducing basal and stimulated secretion, regardless of the nature of the stimulus. Prescribed for gastric ulcer and duodenal ulcer in acute phase, erosive-ulcerative esophagitis, reflux esophagitis, Zollinger-Ellison syndrome, stress ulcers of the gastrointestinal tract; eradication of Helicobacter pylori within a combination therapy, non-ulcer dyspepsia.